The disease is too complex, experts argue. But drugmakers are still hoping for a foot in that lucrative door. In other pharmaceutical news: insulin drug pricing, pharmacy benefits managers, postpartum depression drugs, a rare genetic disease, and more.
from Kaiser Health News https://ift.tt/2TrTYrD
Rose
0 comments:
Post a Comment